Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Debt to Equity (2021 - 2023)

Pulse Biosciences has reported Debt to Equity over the past 3 years, most recently at -$6.09 for Q1 2023.

  • Quarterly results put Debt to Equity at -$6.09 for Q1 2023, changed N/A from a year ago — trailing twelve months through Mar 2023 was -$6.09 (changed N/A YoY), and the annual figure for FY2022 was -$28.91, changed.
  • Debt to Equity for Q1 2023 was -$6.09 at Pulse Biosciences, up from -$28.91 in the prior quarter.
  • Over the last five years, Debt to Equity for PLSE hit a ceiling of $10.5 in Q3 2022 and a floor of -$28.91 in Q4 2022.
  • Median Debt to Equity over the past 3 years was -$2.04 (2021), compared with a mean of -$5.62.